參考文獻(xiàn)/References:
[1] Appel H, Loddenkemper C, Sieper J.Immunopathology of ankylosing spondylitis and
other spondyloarthritides[J].Zeitschriftfur Rheumatologie,2008,67(1):25-31.
[2] ZHAO Z,WANG G,WANG Y,et al.SAT0432 Correlation between the spinal MRI
findings and new bone formation factor(DKK-1)in patients with spondyloarthritis
[J].Clin Rheumatol,2017,76(11):935.
[3] 萬(wàn)雷,黃宏興,黃紅,等.沉默DKK1、Sost重組腺病毒載體的構(gòu)建及其對(duì)MG63細(xì)胞增殖、
ALP活性和鈣離子濃度影響研究[J].中國(guó)骨質(zhì)疏松雜志,2016,22(11):1361-1369.
[4] 蘭維婭,唐芳,馬武開,等.Wnt/β-catenin抑制劑DKK1調(diào)控類風(fēng)濕關(guān)節(jié)炎的研究進(jìn)展
[J].中國(guó)老年學(xué)雜志,2018,38(8):2015-2017.
[5] 張陽(yáng)洋,高艷虹.Sclerostin 單克隆抗體治療骨質(zhì)疏松的研究進(jìn)展[J].中國(guó)骨質(zhì)疏松
雜志, 2017, 23(10):1376-1380.
[6] 王吉利,萬(wàn)雷,張志海,等.抑制Dickkopf-1 和Sclerostin表達(dá)對(duì)人成骨肉瘤細(xì)胞MG63
骨代謝調(diào)節(jié)相關(guān)蛋白表達(dá)水平的影響[J].中醫(yī)正骨, 2016, 28(9): 653-658.